Presentation TCT 2016

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions What FDA Would Like to See

Presenter: Katherine Wallon

November 01, 2016

REGISTER for free or LOG IN to view this content

Trial Designs For LAA Closure: Potential Regulatory Pathways and Unanswered Questions – What FDA Would Like to See

Structural Heart

Presentation

TCT 2016

Left Atrial Appendage

Up Next

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Mahmood K. Razavi

November 01, 2016

More slides +

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

TCT 1055: Retrograde Treatment of a Flush Right Coronary Artery Chronic Total Occlusion

Presenter: Judit Karacsonyi

November 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.